Complete Story


Pfizer Expected to Seek Authorization for COVID-19 Booster for People 18 and Older

If authorized, the move could bolster protection for Americans

Pfizer and its German partner BioNTech are expected to seek authorization for their coronavirus vaccine booster shot for anyone 18 and older, a move that could increase booster rates at a critical moment in the pandemic, according to three officials familiar with the situation.

The request, which may be filed as soon as this week, is likely to win the backing of the Food and Drug Administration, said the individuals, who spoke on the condition of anonymity because they were not authorized to discuss the issue. That would essentially fulfill the Biden administration's booster-for-all-adults goal, announced last August amid concerns about waning vaccine protection.

Pfizer spokesman Kit Longley declined to confirm the company’s plans, saying he had no update on boosters.

Please select this link to read the complete article from The Washington Post.

Printer-Friendly Version